These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28056526)

  • 1. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
    Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
    Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
    Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
    Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
    J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
    St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemobiocatalytic Synthesis of a Low-Molecular-Weight Heparin.
    Yu Y; Fu L; He P; Xia K; Varghese S; Wang H; Zhang F; Dordick J; Linhardt RJ
    ACS Chem Biol; 2022 Mar; 17(3):637-646. PubMed ID: 35201757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of sulfation degree of heparin and low molecular weight heparins by capillary electrophoresis].
    Shen Y; Kang J
    Se Pu; 2020 Oct; 38(10):1238-1242. PubMed ID: 34213122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation.
    Xie S; Guan Y; Zhu P; Li F; Yu M; Linhardt RJ; Chi L; Jin L
    Carbohydr Polym; 2018 Oct; 197():83-91. PubMed ID: 30007661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety--a review.
    Ingle RG; Agarwal AS
    Carbohydr Polym; 2014 Jun; 106():148-53. PubMed ID: 24721062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.
    Smith RE; Townsend GE; Berry BR; Bowen T
    Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview on guidelines and recommendations for generic low-molecular-weight heparins.
    Harenberg J
    Thromb Res; 2011 Feb; 127 Suppl 3():S100-4. PubMed ID: 21262425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR.
    Liu X; St Ange K; Wang X; Lin L; Zhang F; Chi L; Linhardt RJ
    Anal Chim Acta; 2017 Apr; 961():91-99. PubMed ID: 28224913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
    Xu X; Li D; Chi L; Du X; Bai X; Chi L
    Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism.
    Ornstein DL; Hong-Dice YG; Papini JR
    Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Top-down and bottom-up analysis of commercial enoxaparins.
    Liu X; St Ange K; Lin L; Zhang F; Chi L; Linhardt RJ
    J Chromatogr A; 2017 Jan; 1480():32-40. PubMed ID: 28011077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins.
    Houiste C; Auguste C; Macrez C; Dereux S; Derouet A; Anger P
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):50-8. PubMed ID: 18805847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
    Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
    Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.